With 2.23 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.75 million shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $0.7748 whereas the lowest price it dropped to was $0.65. The 52-week range on TRIB shows that it touched its highest point at $3.44 and its lowest point at $0.48 during that stretch. It currently has a 1-year price target of $15.00. TRIB paid its most recent dividend on 1433462400, while the ex-dividend date for that was 1433462400. Beta for the stock currently stands at 0.82.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of TRIB was up-trending over the past week, with a rise of 22.95%, but this was up by 8.23% over a month. Three-month performance surged to 11.36% while six-month performance fell -2.60%. The stock lost -14.79% in the past year, while it has lost -69.76% so far this year.
Float and Shares Shorts:
At present, 18.59 million TRIB shares are outstanding with a float of 18.57 million shares on hand for trading. On 2025-05-30, short shares totaled 37686.0, which was 20.0 higher than short shares on 1745971200. In addition to Mr. John Gillard as the firm’s President, CEO, Company Secretary & Director, Mr. Ronan O’Caoimh A.C.A. serves as its Founder, Director & Executive Advisor.
Institutional Ownership:
Through their ownership of 0.046240002 of TRIB’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-12-31, TRIB reported revenue of $15857000.0 and operating income of -$8564000.0. The EBITDA in the recently reported quarter was -$8428000.0 and diluted EPS was $nan.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$1.74 being high and -$1.74 being low. For TRIB, this leads to a yearly average estimate of -$1.74.
